Highlighting its commitment to promote the safety and welfare of its employees, Teleperformance Philippines will be offering free Covid-19 vaccinations for their more than 47,000 employees in the country nationwide.
This is in line with the global initiative of
Teleperformance to provide free access to vaccines for all its employees
worldwide. As the nation awaits the ongoing government reviews to allow
distribution of the vaccine, Teleperformance Philippines is currently collaborating
with government agencies and employers in the country to quickly secure the
supply of safe and effective FDA-approved vaccines for 100% of their employees.
Teleperformance, a leading global group in digitally
integrated business services recently announced its plans to reimburse the
cost of Covid-19 vaccinations for its more than 330,000 employees worldwide,
wherever the vaccine is not being provided free of charge by the country’s
healthcare system. The plan will be deployed in accordance with the decisions
of the local authorities concerned and in partnership with key private
healthcare partners across Teleperformance’s footprint, which spans 80
countries.
Since the start of the Covid-19 crisis, Teleperformance
has paid careful attention to protecting its employees, notably with a strong
focus on health and hygiene standards in all its locations, millions of masks
proactively secured and distributed to its staff, the assertive move to a Work-at-Home
delivery model in conjunction with its clients, and enforcement of extra
physical distance at its operational sites, over and above local country
guidelines.
A Great Place to Work® certified company, Teleperformance
Philippines likewise initiated efforts throughout the pandemic to promote the
safety and well-being of their employees while helping businesses adjust to the
new environment. Aside from stringent health and safety protocols on-site, they
also implemented the work-at-home (WAH) model for thousands of employees
and launched Teleperformance Cloud
Campus, a model that allows home-based interaction experts to work from
anywhere in the world while remaining connected virtually to their Teleperformance
team through one of the Cloud Campus hubs.
Today, by offering the vaccine as a free, optional staff
benefit, Teleperformance aims not only to honor its commitment to protecting
the health of its people, but also to help governments address the pandemic
with agile, large-scope support of vaccination programs deployed at the
corporate level.
Teleperformance Chairman and
Chief Executive Officer Daniel Julien remarked, “Nothing is more
important in fulfilling our mission than the safety and health of all our
employees. Since the beginning of this grave crisis, we have done everything in
our power to ensure business continuity for our clients and protect the health
and safety of our employees, our partners, and jobs in the communities where the
Group is present. Now, more than ever, we are focused on the same priorities.
Based on strong relationships with healthcare partners and in compliance with
government decisions and procurement agendas, we are well prepared across the
world to assist in securing critical Covid-19 vaccinations for our employees.
The reimbursement of vaccination costs for our staff is another critical step
in this commitment to our employees. We will support every employee in the
Group who wants the vaccine, especially in countries where the public or
private insurance system doesn’t cover the cost. We are also proud to be
actively contributing to the ongoing fight against the virus by boosting
vaccinations worldwide.”
Teleperformance Chief Executive
Officer for US, Canada, and Philippines Mike Lytle added, “From
the beginning, the safety and well-being of our employees has been our priority.
While the past year has definitely been a challenging one for the company and
its many employees and partners, the announcement of the vaccine brings hope
for everyone across the globe and we are committed to giving free access to
this for all our employees. As we wait for the distribution of the vaccine, we
continue to maintain a positive outlook for the industry and the country. We enjoin
everyone in the ongoing fight against Covid-19 by continuing to follow the
government’s lead and practice safety measures and protocols wherever they are.”
